Compound classLong-acting synthetic GHRH analogue with Drug Affinity Complex
Peptide length29-residue GHRH analogue with DAC modification
Molecular formulaC165H269N47O46
Molecular weight3647.2 g/mol
Primary targetGHRH receptor (GHRHR)
Key design featureMaleimide/DAC modification designed for albumin binding and prolonged exposure
Scientific profileCJC-1295 with DAC is a modified GHRH analogue designed to form an albumin-associated depot through its Drug Affinity Complex, producing prolonged GH/IGF-1 signalling relative to short-acting GHRH analogues.
No CAS number is displayed because the exact supplied material has not been confirmed.
Reviews
There are no reviews yet.